Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle
β Scribed by Naohiro Terada; Joseph J. Lucas; Agota Szepesi; Richard A. Franklin; Joanne Domenico; Erwin W. Gelfand
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 837 KB
- Volume
- 154
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
β¦ Synopsis
ot B d S l C k i ~n c c s , Department ot Pediatrics, National lcwish Center for /mmuno/ogy and Rcspiratory Med,one, a n d h e Raymond and Beverly Sackler Foundation,
π SIMILAR VOLUMES
## Abstract **Background:** Cell lines that stably overβexpress protein kinase C (PKC) Ξ΄ frequently show a decrease in growth rate and saturation density, leading to the hypothesis that PKCΞ΄ has a negative effect on cell proliferation. However, the mode of PKCΞ΄ activation, the cell cycle stage requ
## Abstract T and B lymphocytes stimulated with mitogens develop 'HMR spectra characteristic of triglycerides in an isotropic environment. These distinctive signals, which are also observed in malignant cells, cannot be suppressed by compounds which inhibit progression through the cell cycle. Cellu
Opioids decrease cell proliferation in different systems including breast, prostate, lung, kidney, and intestine, through an interaction with opioid as well as other membrane-receptor systems (somatostatin, cholinergic), through an unidentified mechanism. Recently, we have reported an interaction of